Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine ER Cognitive Effects in Elderly
NCT00411437Phase 4Completed
- Sponsor
- Viatris
- Start
- Dec 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolterodine in overactive bladder (OAB), sponsored by Viatris. Started Dec 2006; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00411437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411437.